Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Tony B Awardee
Food/Beverage Available
Data Science and AI Parallel Path
Lab Automation Parallel Path
Home
Type here to filter the list
Frontiers in Technology
Tuesday, May 28th
11:30 – 13:00
CEST
AI & Computation in healthcare
Room/Location: 112
Patricia B. Maguire, PhD
– University College Dublin - UCD Institute for Discovery
Frontiers in Technology
Tuesday, May 28th
11:30 – 12:00
CEST
AI_PREMie: A Novel AI-Powered Clinical Decision Support Tool for the Diagnosis and Risk Stratification of Preeclampsia
Room/Location: 112
Ana Le Chevillier, BSc, MSc (she/her/hers)
– University College Dublin
Frontiers in Technology
Data Science and AI Parallel Path
Tuesday, May 28th
12:00 – 12:30
CEST
Opportunities in Data Science Research and Education: Navigating Real-World Data
Room/Location: 112
Justin Manjourides, PhD
– Northeastern University
Frontiers in Technology
Tuesday, May 28th
12:30 – 13:00
CEST
Convergence of Digital Lab and GenAI to accelerate drug discovery
Room/Location: 112
Soumen Ghosh, BE, MBA (he/him/his)
– Amazon Web Services
James Pena
Frontiers in Technology
Data Science and AI Parallel Path
Tuesday, May 28th
14:30 – 16:00
CEST
Screening approaches to tackle challenging targets
Room/Location: 112
Melanie Leveridge, Bsc Hons (she/her/hers)
– AstraZeneca
Frontiers in Technology
In partnership with
Tuesday, May 28th
14:30 – 15:00
CEST
Reactive fragment platforms for covalent hit identification
Room/Location: 112
Emma K. Grant, MSci, PhD (she/her/hers)
– GlaxoSmithKline
Frontiers in Technology
In partnership with
Tuesday, May 28th
15:00 – 15:30
CEST
Targeting RNA via small molecule exon skippers: development of high throughput RT-qPCR platform to assess targeted RNA.
Room/Location: 112
Giulia Bonetto, PhD (she/her/hers)
– AstraZeneca
Frontiers in Technology
In partnership with
Tuesday, May 28th
15:30 – 16:00
CEST
Development of a functional cell-based assay and cellular thermal shift for evaluation of drug target interactions with Phospholipase C-gamma 2, PLCɣ2.
Room/Location: 112
Fiona Elaine Jeganathan, PhD
– Alzheimer's Research UK - University College London Drug Discovery Institute
Frontiers in Technology
In partnership with
Wednesday, May 29th
11:30 – 13:00
CEST
Cellular Technologies
Room/Location: 112
Lorna AB Suckling, PhD (she/her/hers)
– GSK
Frontiers in Technology
Wednesday, May 29th
11:30 – 12:00
CEST
Development of acoustic ejection mass spectrometry for label-free cellular based assays for solute carrier transporter targets in drug discovery
Room/Location: 112
Amy Burton (she/her/hers)
– GSK
Frontiers in Technology
Wednesday, May 29th
12:00 – 12:30
CEST
Advancing morphological profiling of cells using AI and automation
Room/Location: 112
Ola Spjuth, PhD (he/him/his)
– Uppsala University
Frontiers in Technology
Wednesday, May 29th
12:30 – 13:00
CEST
Automation of 3D organoid culture and assays powered by machine learning and advanced image analysis.
Room/Location: 112
Oksana Sirenko, PhD (she/her/hers)
– Molecular Devices
Frontiers in Technology
Wednesday, May 29th
14:30 – 16:00
CEST
Sample Management Technology
Room/Location: 112
Karin Kaspersson, MSc (she/her/hers)
– AstraZeneca
Frontiers in Technology
Wednesday, May 29th
14:30 – 15:00
CEST
Challenges and Opportunities of Next Generation Therapeutics: a Compound Management Perspective
Room/Location: 112
Martin Svensson, Mr
– AstraZeneca
Frontiers in Technology
Wednesday, May 29th
15:00 – 15:30
CEST
Sample Management and Automation in Agriculture
Room/Location: 112
Lennon Glass (he/him/his)
– FMC
Frontiers in Technology
Wednesday, May 29th
15:30 – 16:00
CEST
Revolutionizing Sample and Material Flow: Real-World Applications of Mobile Robotics in Lab Environments
Room/Location: 112
Karlis Akis
– NovaticLab
Frontiers in Technology
Lab Automation and Screening Parallel Path
Screening Applications & Diagnostics
Tuesday, May 28th
11:30 – 13:00
CEST
The New Automation, Decentralization and Point Of Care
Room/Location: 111
Ricard Martin, MBA (he/him/his)
– QIAGEN
Screening Applications & Diagnostics
Tuesday, May 28th
11:30 – 12:00
CEST
The Past, Present and Future of Point of Care Diagnostics
Room/Location: 111
Ayden Malekjahani, ECCMID speaker 2023
– EY-Parthenon
Screening Applications & Diagnostics
Tuesday, May 28th
12:00 – 12:30
CEST
Mobile Analytical Anticounterfeiting Drug Screening Device for Patient Safety
Room/Location: 111
Dominik G. Rabus, PhD (he/him/his)
– RABUS.TECH
Screening Applications & Diagnostics
Tuesday, May 28th
12:30 – 13:00
CEST
Challenging the status quo with Molecular Syndromic Testing
Room/Location: 111
Ricard Martin, MBA (he/him/his)
– QIAGEN
Screening Applications & Diagnostics
Tuesday, May 28th
14:30 – 16:00
CEST
The next big pandemic: Sepsis and Antibiotic Resistance Management, an increasing need for better screening and diagnostics
Room/Location: 111
Enrique Hernández Jiménez, PhD
– Loop Diagnostics S.L.
Screening Applications & Diagnostics
Tuesday, May 28th
14:30 – 15:00
CEST
Enhancing Sepsis Recognition and Treatment: A Multifaceted Personalized Approach
Room/Location: 111
Hjalmar Bouma, MD, PhD, EuCP (he/him/his)
– University Medical Center Groningen
Screening Applications & Diagnostics
Tuesday, May 28th
15:00 – 15:30
CEST
Transforming point-of-care diagnostics: The power of silicon plasmonic biosensors in the battle against acute infections
Room/Location: 111
Dimitris Tsiokos
– Bialoom Ltd
Screening Applications & Diagnostics
Lab Automation and Screening Parallel Path
Tuesday, May 28th
15:30 – 16:00
CEST
Integration of wide-field imaging system with droplet microfluidics for monitoring living bacteria
Room/Location: 111
Sunghyun Ki (he/him/his)
– Incheon National University
Screening Applications & Diagnostics
Lab Automation and Screening Parallel Path
Award Winner
Wednesday, May 29th
11:30 – 13:00
CEST
AI, Machine learning and Big data on the rise for Screening and Diagnostics
Room/Location: 111
Steve Shih, PhD (he/him/his)
– Concordia University
Screening Applications & Diagnostics
Wednesday, May 29th
11:30 – 12:00
CEST
Translational Application of Nanostructured Biosensors: Diagnostics at the Point of Care
Room/Location: 111
Sara Mahshid, Canada Research Chair
– Department of Bioengineering, McGill University
Screening Applications & Diagnostics
Wednesday, May 29th
12:00 – 12:30
CEST
An Automated High-Throughput Platform for AI-Guided Development of Nanopore Membrane Biosensors and Real-time Edge Processing
Room/Location: 111
Shitanshu Devrani, Btech, MSc
– University of Gothenburg
Screening Applications & Diagnostics
Lab Automation and Screening Parallel Path
Award Winner
Wednesday, May 29th
12:30 – 13:00
CEST
Machine learning and digital microfluidics - a new route for high-throughput studies
Room/Location: 111
Steve Shih, PhD (he/him/his)
– Concordia University
Screening Applications & Diagnostics
Data Science and AI Parallel Path
Wednesday, May 29th
14:30 – 16:00
CEST
The Sequencing revolution
Room/Location: 111
Jessica Nordlund, MSc, PhD (she/her/hers)
– SciLifeLab, Uppsala University
Screening Applications & Diagnostics
Wednesday, May 29th
14:30 – 15:00
CEST
A brief History of four Generations of Sequencing Technologies and their Impact on the World
Room/Location: 111
Ivo G. Gut, PhD (he/him/his)
– Centro Nacional de Análisis Genómico (CNAG)
Screening Applications & Diagnostics
Wednesday, May 29th
15:00 – 15:30
CEST
Assaying drug response on patient biopsies and screening hundred thousands of antibodies in one go – the magic of microfluidics
Room/Location: 111
Christoph Merten
– EPFL, The Swiss Federal Institute of Technology of Lausanne
Screening Applications & Diagnostics
Wednesday, May 29th
15:30 – 16:00
CEST
NGS-BASED PROTEOMICS DRIVES A SYSTEMATIC APPROACH TO IDENTIFY CAUSAL THERAPEUTIC TARGETS IN LARGE POPULATION HEALTH COHORTS LIKE THE UK BIOBANK
Room/Location: 111
Cindy Lawley, PhD (she/her/hers)
– Olink Proteomics
Screening Applications & Diagnostics
Shaping the Future of Therapeutics
Tuesday, May 28th
11:30 – 13:00
CEST
Oligo therapeutics and delivery
Room/Location: 113
Joanna Rejman, PhD (she/her/hers)
– AstraZeneca
Shaping the Future of Therapeutics
Sponsored By
Tuesday, May 28th
11:30 – 12:00
CEST
LNP Formulation Development through Innovative DMTA Technologies
Room/Location: 113
Audrey Gallud, PhD
– AstraZeneca
Shaping the Future of Therapeutics
Sponsored By
Tuesday, May 28th
12:00 – 12:30
CEST
Engineering circular RNA nanotherapeutics
Room/Location: 113
Piotr S. Kowalski (he/him/his)
– University College Cork
Shaping the Future of Therapeutics
Sponsored By
Tuesday, May 28th
12:30 – 13:00
CEST
Multiplexed detection of single-point mutations in human serum by integrating Surface Enhanced Raman Scattering with Polymerase Chain Reaction.
Room/Location: 113
Joel Sanchez Barea
– Incheon National University
Shaping the Future of Therapeutics
Lab Automation and Screening Parallel Path
Sponsored By
Tuesday, May 28th
14:30 – 16:00
CEST
Data/AI Driven Drug Discovery
Room/Location: 113
Jordi Carreras Puigvert (he/him/his)
– Uppsala University - Phenaros Pharmaceuticals
Shaping the Future of Therapeutics
Sponsored By
Tuesday, May 28th
14:30 – 15:00
CEST
AI in Drug Discovery - Approaches, Current Status, and Challenges
Room/Location: 113
Andreas Bender
– Cambridge University
Shaping the Future of Therapeutics
Data Science and AI Parallel Path
Sponsored By
Tuesday, May 28th
15:00 – 15:30
CEST
Putting large language models into action for target Identification
Room/Location: 113
James Dunbar, DPhil (he/him/his)
– BenevolentAI
Shaping the Future of Therapeutics
Data Science and AI Parallel Path
Sponsored By
Tuesday, May 28th
15:30 – 16:00
CEST
Automating the DMTA cycle in Astrazeneca
Room/Location: 113
Thomas Jones
– AstraZeneca
Shaping the Future of Therapeutics
Data Science and AI Parallel Path
Sponsored By
Wednesday, May 29th
11:30 – 13:00
CEST
Future for assesment of drug safety, toxicology and efficacy
Room/Location: 113
David J. Baker, PhD (he/him/his)
– AstraZeneca
Shaping the Future of Therapeutics
Sponsored By
Wednesday, May 29th
11:30 – 12:00
CEST
Human bone marrow organoids as an alternative to animal models of blood cancer
Room/Location: 113
Abdullah O. Khan, BSc (Hons) MRes PhD
– University of Oxford
Shaping the Future of Therapeutics
Sponsored By
Wednesday, May 29th
12:00 – 12:30
CEST
Innovating Drug Development: the Revolution of Organ-on-a-Chip Technology in Enhancing Safety and Efficacy Assessments
Room/Location: 113
Asli Akidil (she/her/hers)
– Emulate
Shaping the Future of Therapeutics
Sponsored By
Wednesday, May 29th
12:30 – 13:00
CEST
Robotic device for fully automated high-content screening on C. elegans as a novel NAMs platform for early toxicity assessment
Room/Location: 113
Marie Pierron, PhD
– Nagi Bioscience
Shaping the Future of Therapeutics
Sponsored By
Wednesday, May 29th
14:00 – 15:00
CEST
ASPIRE: Re-imagining the Research Laboratory Ecosystem for Automated Chemistry
Room/Location: Exhibition Theatre
Lesley Mathews (she/her/hers)
– SLAS
Shaping the Future of Therapeutics
Data Science and AI Parallel Path
Wednesday, May 29th
14:30 – 16:00
CEST
Precision medicine and drug repositioning
Room/Location: 113
Krister Wennerberg, PhD (he/him/his)
– University of Copenhagen
Shaping the Future of Therapeutics
Sponsored By
Wednesday, May 29th
14:30 – 15:00
CEST
Precision targeting of drug resistance in primary cancer cell models
Room/Location: 113
Krister Wennerberg, PhD (he/him/his)
– University of Copenhagen
Shaping the Future of Therapeutics
Sponsored By
Wednesday, May 29th
15:00 – 15:30
CEST
The Broad Institute Repurposing Hub: a Small Molecule Toolbox for Interrogating Biological Pathways in Disease Models
Room/Location: 113
Jaime Cheah, PhD (she/her/hers)
– Broad Institute of MIT and Harvard
Shaping the Future of Therapeutics
Lab Automation and Screening Parallel Path
Sponsored By
Wednesday, May 29th
15:30 – 16:00
CEST
International collaboration is key for successful patient-centric drug repurposing and repositioning
Room/Location: 113
Donald C. Lo, PhD (he/him/his)
– EATRIS
Shaping the Future of Therapeutics
Sponsored By
